del Castillo D et al. |
Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients. |
1998 |
Kidney Int. Suppl. |
pmid:9839298
|
Navarro-AntolÃn J et al. |
CsA and FK506 up-regulate eNOS expression: role of reactive oxygen species and AP-1. |
1998 |
Kidney Int. Suppl. |
pmid:9839278
|
Sho M et al. |
Simultaneous inoculation of donor lymphocyte subsets with transplantation in a rat cardiac allograft model. |
1998 |
Transplant. Proc. |
pmid:9838696
|
Sanada O et al. |
Establishment of chimerism in donors by intraportal injection of recipient-type bone marrow cells with concomitant administration of FK 506 before liver transplantation prolongs liver allograft survival in rats. |
1998 |
Transplant. Proc. |
pmid:9838689
|
Nishimura Y et al. |
A trial to obtain donor-specific immunotolerance using a vascularized thymus allograft. |
1998 |
Transplant. Proc. |
pmid:9838684
|
Fukushima N et al. |
Prolonged survival of pig cardiac xenografts in baboons by sequential cardiac transplantation. |
1998 |
Transplant. Proc. |
pmid:9838671
|
Takeda M et al. |
Immunologic factors contributing to acute rejection in lungs xenotransplanted between primates. |
1998 |
Transplant. Proc. |
pmid:9838670
|
Hattori R et al. |
FK 506 in cadaveric kidney transplantation from non-heart-beating donors. |
1998 |
Transplant. Proc. |
pmid:9838666
|
Watanabe Y et al. |
Enteric absorption of FK 506: estimation by a block liver perfusion technique in rats. |
1998 |
Transplant. Proc. |
pmid:9838656
|
Takada Y et al. |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist. |
1998 |
Transplant. Proc. |
pmid:9838621
|
Watanabe K et al. |
Prolongation effect of FK506 on the survival of 3-day preserved kidney allografts in dogs. |
1998 |
Transplant. Proc. |
pmid:9838579
|
Yamauchi M et al. |
Effects of FK506 on rat thymic microenvironment in thymocyte maturation, proliferation, and mobilization. |
1998 |
Transplant. Proc. |
pmid:9838578
|
Yura H et al. |
Development of a macromolecular prodrug of FK506: I. Synthesis of FK506-dextran conjugate. |
1998 |
Transplant. Proc. |
pmid:9838577
|
Jeong HJ et al. |
Vascular endothelin, TGF-beta, and PDGF expression in FK506 nephrotoxicity of rats. |
1998 |
Transplant. Proc. |
pmid:9838576
|
Goh BL and Tan SY |
FK506 "rescue" therapy complicated by renal tubular acidosis in renal allograft recipients. |
1998 |
Transplant. Proc. |
pmid:9838575
|
Goh BL et al. |
FK506 rescue therapy for acute renal allograft rejection. |
1998 |
Transplant. Proc. |
pmid:9838574
|
Cheng HM et al. |
Primary prophylaxis with tacrolimus in kidney transplants in China. |
1998 |
Transplant. Proc. |
pmid:9838573
|
Hung CM et al. |
Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838572
|
Lo CM et al. |
Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong. |
1998 |
Transplant. Proc. |
pmid:9838571
|
Shu KH et al. |
A multicenter trial of FK506 as rescue therapy for renal transplant recipients in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838570
|